ARTICLE | Clinical News
Nesina alogliptin regulatory update
August 30, 2010 7:00 AM UTC
Japan's Ministry of Health and Welfare approved Takeda's Nesina alogliptin for use in combination with thiazolidinediones to treat Type II diabetes. The once-daily didpeptidyl peptidase-4 ( DPP-4) inh...